- Title
- P1.07-024 ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but Not Chemotherapies or Targeted Kinase Inhibitors
- Creators
- W Park - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USD Kwon - Department of Medicine, Biostatistics and Bioinformatics, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USA Desai - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USV Florou - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USD Saravia - Internal Medicine, University of Miami Miller School of Medicine, Miami, FL/USJ Warsch - Radiology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USY.K Chae - Developmental Therapeutics Program of the Division of Hematology Oncology Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL/USA Ishkanian - Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami FL/USM Jahanzeb - Medical Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami/USR Mudad - Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL/USG Lopes - Global Oncology, Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL/US
- Publication Details
- Journal of thoracic oncology, Vol.12(11), pp.S2005-S2005
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Department of Public Health Sciences Research; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031598546002976
Journal article
P1.07-024 ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but Not Chemotherapies or Targeted Kinase Inhibitors
Journal of thoracic oncology, Vol.12(11), pp.S2005-S2005
2017-11
Metrics
5 Record Views